CTRI/2024/07/071545尚未招募4 期
A comparative study of amlodipine and telmisartan to assess the impact on glycemic status, lipid profile and renal parameters in drug naive hypertensive patients in eastern India.
Midnapore medical college and hospital1 个研究点 分布在 1 个国家目标入组 220 人开始时间: 2024年8月9日最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 220
- 试验地点
- 1
- 主要终点
- The study will give us knowledge and effectiveness and adverse effects of amlodipine and telmisartan and comparing the effects of these two drugs on glycemic status ,lipid profile and renal parameters.
研究概览
简要总结
The study result could lead to changes in current guidelines for managing hypertension and inform drug selection for hypertensive patients in the future.In conclusion,the proposed study is highly relevant and could lead to significant improvement in the management of hypertension in eastern India reducing the risk of developing associated complications.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 65.00 Year(s)（—）
- 性别
- All
入选标准
- •1.Patient aged between 18 and 65 years.
- •2.Patients newly diagnosed with hypertension(systolic blood pressure ≥140 mm hg and/or diastolic pressure ≥90 mmhg) 3.Patients with no history of diabetes mellitus,renal disease or hyperlipidemia.
- •4.Patients who provide informed consent to participate in the study.
排除标准
- •1.Patients who are already taking antihypertensive medications.
- •2.Patients with a history of allergic reactions to amlodipine or telmisartan.
- •3.Patients with a history of chronic diseases,such as diabetes mellitus,renal disease,or hyperlipidemia.
- •5.Pregnant or lactating women.
- •6.Patients who are unable or unwilling to provide informed consent.
- •7.Patients who are not taking any other medications that interfere glycemic status,lipid profile and renal parameters.
结局指标
主要结局
The study will give us knowledge and effectiveness and adverse effects of amlodipine and telmisartan and comparing the effects of these two drugs on glycemic status ,lipid profile and renal parameters.
时间窗: Data will be collected at baseline,3 months and 6 months.
次要结局
- To study the adverse effect of both the drugs in these patients.
研究者
Subhajit Karmakar
Midnapore medical college and hospital
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
不适用
Effects of single-pill combination of telmisartan/amlodipine and telmisartan/amlodipine/hydrochlorothiazide on 24-hour blood pressure (BP) reduction, 24-h BP variability and office BP control in patients with arterial hypertension – SATELLITE2023-504812-13-00KRKA tovarna zdravil d.d. Novo mesto, KRKA tovarna zdravil d.d. Novo mesto, KRKA tovarna zdravil d.d. Novo mesto110
尚未招募
不适用
An observational study to check if Azelnidipine and Telmisartan combination is effective and safe in patients with high blood pressure.CTRI/2025/10/095717Torrent Pharmaceuticals Ltd.4,000
尚未招募
不适用
REMIDEP-HTA Program for Hypertension Remission and Medication DeprescriptionNCT07424118Evelyn Vanina Re240
尚未招募
3 期
Timing of Telmisartan (40 mg) for Treating High Blood Pressure in Diabetic Patients: A Study of Blood Pressure Changes During Exercise and Monitoring Through the DayCTRI/2025/08/092351department of general medicine40
尚未招募
不适用
My study is about comparing the changes in blood pressure in patients having BP 140/90 to 160/100 mmHg with Vitamin D levels of 20 to 29 ng/mL taking standard of treatment which is tablet Telmisartan 40mg alone in one group and tablet Telmisartan 40mg with Vitamin D supplementation in another groupCTRI/2025/11/09759284